Preliminary data on Pemphigus vulgaris treatment by a proteomics-defined peptide: a case report

BACKGROUND: Although described by Hippocrates in 400 B.C., pemphigus disease still needs a safe therapeutical approach, given that the currently used therapies (i.e. corticosteroids and immunosuppressive drugs) often provoke collateral effects. Here we present preliminary data on the possible use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelini, Giovanni, Bonamonte, Domenico, Lucchese, Alberta, Favia, Gianfranco, Serpico, Rosario, Mittelman, Abraham, Simone, Simone, Sinha, Animesh A, Kanduc, Darja
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1630706/
https://www.ncbi.nlm.nih.gov/pubmed/17062151
http://dx.doi.org/10.1186/1479-5876-4-43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1630706/
https://www.ncbi.nlm.nih.gov/pubmed/17062151
http://dx.doi.org/10.1186/1479-5876-4-43

Ejemplares similares